An observational study of efficacy, safety, and side effect profile of fremanezumab in patients with refractory migraine and medication-overuse headache in a Portuguese tertiary hospital
Latest Information Update: 08 Feb 2023
At a glance
- Drugs Fremanezumab (Primary)
- Indications Migraine; Secondary headache disorders
- Focus Therapeutic Use
Most Recent Events
- 08 Feb 2023 New trial record
- 10 Dec 2022 Results presented at the 16th European headache federation COngress